two doses enterovirus 71 vaccine — Competitive Intelligence Brief

two doses enterovirus 71 vaccine (two doses enterovirus 71 vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated viral vaccine. Area: Infectious Disease / Immunology.

marketed inactivated viral vaccine Enterovirus 71 viral antigens Infectious Disease / Immunology Biologic

Target snapshot

two doses enterovirus 71 vaccine (two doses enterovirus 71 vaccine) — Beijing Chaoyang District Centre for Disease Control and Prevention. This inactivated vaccine stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71, preventing infection and disease.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
two doses enterovirus 71 vaccine TARGET	two doses enterovirus 71 vaccine	Beijing Chaoyang District Centre for Disease Control and Prevention	marketed	inactivated viral vaccine	Enterovirus 71 viral antigens
Havrix (HAV)	Havrix (HAV)	Pfizer	marketed	Inactivated viral vaccine	Hepatitis A virus antigen
Hepatitis A (control)	Hepatitis A (control)	International Vaccine Institute	marketed	inactivated viral vaccine	Hepatitis A virus surface antigens
Havrix+Havrix	Havrix+Havrix	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Hepatitis A virus (HAV)
IPV at 6 weeks of age	IPV at 6 weeks of age	Centers for Disease Control and Prevention	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
Havrix Junior	Havrix Junior	GlaxoSmithKline	marketed	Inactivated viral vaccine	Hepatitis A virus antigen
fIPV (0.2mL) IM	fIPV (0.2mL) IM	Centers for Disease Control and Prevention	marketed	Inactivated viral vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 5 drugs in this class
2. Sinovac Research and Development Co., Ltd. · 2 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
4. Federal University of Espirito Santo · 1 drug in this class
5. International Vaccine Institute · 1 drug in this class
6. MacroGenics · 1 drug in this class
7. Shandong Province Centers for Disease Control and Prevention · 1 drug in this class
8. Beijing Chaoyang District Centre for Disease Control and Prevention · 1 drug in this class
9. Zhejiang Provincial Center for Disease Control and Prevention · 1 drug in this class
10. Centers for Disease Control and Prevention · 1 drug in this class